NCT03816345 2026-03-18
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
Phase 1 Recruiting
Clinical Trials
8 trialsNCT07470151 2026-03-13
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase NA Recruiting
NCT00867269 2026-03-09
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
National Institutes of Health Clinical Center (CC)
Recruiting
NCT07039916 2026-03-06
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Immunovant Sciences GmbH
Phase 3 Recruiting
NCT01280825 2026-03-04
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
University of Chicago
Recruiting
NCT05875155 2026-03-04
Ovarian Tissue Cryopreservation for Fertility Preservation
University of Pittsburgh
Recruiting
NCT06817889 2026-02-27
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Fred Hutchinson Cancer Center
Phase 2 Recruiting
NCT06626919 2026-02-25
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Arcellx, Inc.
Phase 1 Recruiting